Psychological Interventions for Healthcare Workers' Distress Due to COVID-19
Trial Summary
What is the purpose of this trial?
It is expected that large numbers of healthcare workers will experience a broad range of psychological reactions and symptoms including anxiety, depression, moral distress, and trauma symptoms that will cause both significant suffering as well as occupational and social impairment. The purpose of this study is to find interventions which are helpful in treating psychological distress in healthcare workers caring for COVID-19 patients. There are two phases of the study. All participants will take part in Phase I, which consists of 4 sessions over a two-week period of either a narrative writing intervention or a medical music intervention. Participants will be randomly assigned to the narrative writing intervention or medical music intervention. After Phase I, participants will be re-assessed. Healthcare workers who meet criteria for PTSD will be given the option to participate in Phase II of the study, in which they will be offered a choice between one of two evidence-based treatments for PTSD: Interpersonal Therapy (IPT) or Exposure Therapy (ET). Both treatments are comprised of ten 75-minute sessions scheduled twice weekly. Participants will be allowed to choose a preferred treatment in Phase II. After Phase II participants will complete a final assessment concluding the study. All interventions will be offered using distance technology.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on psychotropic medication, it should be stable for at least 60 days before joining the study.
What data supports the effectiveness of the treatment Interpersonal Psychotherapy, IPT, Interpersonal Therapy, Medical Music, Narrative Writing, Prolonged Exposure Therapy, Prolonged Exposure, PE, Exposure Therapy for healthcare workers' distress due to COVID-19?
Research shows that expressive writing, a form of narrative writing, helped healthcare workers reduce symptoms of PTSD, depression, and overall psychological distress during the COVID-19 pandemic. Additionally, music therapy was found to significantly improve emotional well-being and reduce stress in clinical staff working with COVID-19 patients.12345
Is the psychological intervention safe for healthcare workers?
How does the treatment of Medical Music and Narrative Writing differ from other treatments for healthcare workers' distress due to COVID-19?
This treatment is unique because it combines Medical Music and Narrative Writing, which are non-drug interventions focusing on emotional expression and creative engagement. Unlike traditional therapies, it uses music to soothe and writing to help process emotions, offering a novel way to improve mental health by enhancing resilience and reducing psychological distress.13478
Research Team
JoAnn Difede, PhD
Principal Investigator
Weill Medical College of Cornell University
Eligibility Criteria
This trial is for healthcare workers over 18 who have been treating COVID-19 patients and are experiencing psychological distress. They must be able to consent, understand the study's requirements, and if on medication, be stable for 60 days. Those with PTSD can join Phase II. Exclusions include unstable medical conditions, risk of harm to self or others, psychotic disorders, or recent participation in other psychiatric treatment trials.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Phase I Treatment
Participants undergo either a narrative writing intervention or a medical music intervention over 4 sessions in 2 weeks
Phase II Treatment
Participants meeting PTSD criteria choose between Interpersonal Therapy (IPT) or Exposure Therapy (ET), each consisting of ten 75-minute sessions scheduled twice weekly
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Interpersonal Psychotherapy (Behavioural Intervention)
- Medical Music (Behavioural Intervention)
- Narrative Writing (Behavioural Intervention)
- Prolonged Exposure Therapy (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
Dr. Robert Min
Weill Medical College of Cornell University
Chief Executive Officer since 2024
MD, MBA
Dr. Adam R. Stracher
Weill Medical College of Cornell University
Chief Medical Officer since 2024
MD